Kokkedal, Capital Region of Denmark, Denmark
I turn healthcare innovation into real-world solutions. With 15+ years in technology scouting, business development, operations, and innovation, I've helped both startups and global companies in MedTech bring meaningful technologies to patients — from diagnostics to medical devices. What I bring: 🔍 Technology scouting & external innovation — At Coloplast, I scouted 100+ startups, partnerships, and M&A opportunities in bowel, continence, and ostomy care. I evaluated technologies, assessed market potential, and advised leadership — helping shape innovation strategy and open initiatives like our collaboration with the European Innovation Council (EIC). 🚀 Startup scaling & operations — As Co-founder and COO of BluSense Diagnostics, I helped build a team of 50+ across Denmark and Taiwan, raised €27M+, and launched 5 CE-marked IVD diagnostic tests (COVID-19, dengue, Zika). It was all about bridging science and business — ensuring great ideas reached the people who needed them. 👥 People leadership — I'm passionate about motivating teams to reach ambitious goals. At BluSense, I directly led 5 skilled professionals and people leaders across QA, IT, HR, and Finance, while scaling the organization internationally. 🎓 Science meets business — PhD in Microfluidics Engineering combined with an Executive MBA from Copenhagen Business School. I translate complex technologies into clear commercial opportunities. 🌍 International perspective — Lived and worked in 5 countries (Germany, Portugal, Ireland, Denmark, Taiwan). Where I create value: • Technology scouting & scientific/commercial due diligence • External innovation strategy & venture engagement • Deal processes — fundraising, licensing, partnerships, M&A support • Translating complex science into clear value propositions • Building operations and teams from the ground up I'm energized by fast-paced, ambiguous environments where strategy meets execution — and by the people in innovation ecosystems who are building what's next. Currently exploring my next opportunity at the intersection of innovation, business development, and life sciences. Open to conversations — reach out at [email protected]
Advising life science and MedTech startups on technology evaluation, commercialization strategy, and fundraising. • Support development of business plans, pitch decks, and investor materials • Help clients secure €2.5M+ in grant funding (including EU programs) • Challenge scientific assumptions, value propositions, and technical feasibility in early-stage ventures • Provide strategic guidance on market positioning, partnership opportunities, and go-to-market planning
Scouted and evaluated 100+ startups, strategic partnerships, and M&A opportunities across bowel care, continence care, and ostomy care, mapping early- to late-stage technologies globally to accelerate Coloplast’s innovation pipeline. Led cross-functional technical due diligence, assessing clinical validation, regulatory pathways, manufacturing scalability, and IP strength in collaboration with R&D, clinical, and IP teams. Identified emerging trends, market gaps, and high-potential opportunities for Coloplast’s chronic care business areas. Contributed to defined M&A focus areas for Chronic Care Business Areas, preparing deep-dive reports, benchmarking analyses, and recommendations for leadership and steering committees. Presented findings and recommendations to Leadership Team and steering committees, directly informing investment, partnership, and M&A decisions. Supported early-stage technology exploration in Coloplast R&D, providing insights on commercially available and emerging solutions to inform innovation strategy. Launched open innovation call in collaboration with European Innovation Council (EIC) Outcome: 10+ deep-dive reports, contributed to defining M&A themes for bowel care BA, participated in 20+ conferences and trade fairs, connecting numerous start-ups and internal stakeholders.
Consulting the company regarding product planning, product strategy and roadmap as well as mapping market and competitors.
Co-founded and scaled a deep-tech IVD company from research to commercial-stage products, building international operations across Europe and Asia. Leadership & strategy: • Led multidisciplinary teams across science, engineering, operations, and commercial functions • Developed business plans, commercial strategy, and investor presentations • Built HQ in Denmark (43 employees) and subsidiary in Taiwan (12 employees) from the ground up Fundraising & partnerships: • Raised €22M+ in equity financing and €5M+ in grants • Led a multi-company EU-funded consortium (Eurostars project) • Coordinated investment and licensing agreements with legal and financial stakeholders • Managed relationships with investors, partners, and international distributors • Led licensing negotiations with universities and investor due diligence processes Product & operations: • Launched 5 CE-marked diagnostic tests (including COVID-19, dengue, Zika) • Translated nanoparticle-based detection technology and immunoassays into CE-marked diagnostic solutions • Led implementation of quality management system (QMS) per ISO 13485:2016 and IVDR 2017/746 in DK and TW • Successfully passed 10+ audits by notified bodies
Serve as chairman of the board with members in the EU and Taiwan. • Preparing and leading board meetings. • Ensuring that all parties are updated and aligned on company strategy and priorities in order to get buy-in of all stakeholders. Results: • Company raised > 4 mEUR equity financing.
Worked in the group of Anja Boisen on the development of microfluidic systems for automation of liquid handling processes, mainly on centrifugal microfluidic platforms. • Supervised PhD and MSc students. • Author and co-author of 6 publications in peer-reviewed journals and several papers at international conferences